Abiopharma

Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.

Cognition Therapeutics Participating in Upcoming Investor Conferences

PAR Technology Corporation to Participate at the William Blair 46th Annual Growth Stock Conference

Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation

SL Green Announces the Sale of 10 East 53rd Street

XCharge Appoints Albina Iljasov as Co-Chief Executive Officer

Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO

Belo Sun Announces Corporate Update

OptimizeRx to Participate in Upcoming Investor Conferences

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001